17Apr/26
Beyond Single Targets: How Bispecific ADCs Are Redefining Precision Oncology
The ADC Revolution Gets a Dual Upgrade Antibody-drug conjugates have long been celebrated as one of oncology’s most elegant ideas: attach a potent cytotoxic agent to a tumor-targeting antibody, deliver the payloadRead More…
